Medical Video Endoscopes segmentation by application reveals four primary use‑cases that collectively drive market volume. Diagnostic endoscopy, employed for visual assessment of gastrointestinal, respiratory, and urological tracts, accounts for roughly 45 % of total sales, reflecting its prevalence in routine screening and early disease detection. Therapeutic endoscopy, which integrates instrument channels for biopsy, polypectomy, or laser ablation, contributes about 30 % as hospitals adopt minimally invasive treatment protocols. Surgical endoscopy, encompassing video‑assisted thoracic, abdominal, and orthopedic procedures, represents near 20 % of revenue, buoyed by the shift toward laparoscopy and reduced postoperative complications. The remaining 5 % pertains to Research & Development applications, where high‑resolution prototype scopes support pre‑clinical studies and technology validation. These proportions underscore how each application segment underpins the overall market size, with diagnostic use delivering the bulk of unit volumes while therapeutic and surgical segments generate higher average selling prices. Moreover, reimbursement policies increasingly favor endoscopic over open procedures, amplifying the diagnostic segment’s volume growth, whereas therapeutic and surgical segments benefit from premium pricing linked to integrated imaging and navigation capabilities.
